As Glaxo Smithkline Spons Adr (GSK) Stock Price Rose, Choate Investment Advisors Has Trimmed Its Position; Public Sector Pension Investment Board Stake in Sherwin Williams Co (SHW) Has Trimmed by $6.50 Million as Stock Value Declined

May 24, 2018 - By Winifred Garcia

The Sherwin-Williams Company (NYSE:SHW) Logo

Choate Investment Advisors decreased its stake in Glaxo Smithkline Spons Adr (GSK) by 0.28% based on its latest 2017Q4 regulatory filing with the SEC. Choate Investment Advisors sold 123 shares as the company’s stock rose 9.28% while stock markets declined. The institutional investor held 43,285 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $1.54 billion, down from 43,408 at the end of the previous reported quarter. Choate Investment Advisors who had been investing in Glaxo Smithkline Spons Adr for a number of months, seems to be less bullish one the $98.73 billion market cap company. The stock decreased 0.37% or $0.15 during the last trading session, reaching $40.18. About 2.78 million shares traded. GlaxoSmithKline plc (NYSE:GSK) has declined 10.07% since May 24, 2017 and is downtrending. It has underperformed by 21.62% the S&P500.

Public Sector Pension Investment Board decreased its stake in Sherwin Williams Co (SHW) by 63.38% based on its latest 2017Q4 regulatory filing with the SEC. Public Sector Pension Investment Board sold 15,846 shares as the company’s stock declined 5.42% with the market. The institutional investor held 9,154 shares of the building materials company at the end of 2017Q4, valued at $3.75 million, down from 25,000 at the end of the previous reported quarter. Public Sector Pension Investment Board who had been investing in Sherwin Williams Co for a number of months, seems to be less bullish one the $35.78 billion market cap company. The stock increased 2.27% or $8.53 during the last trading session, reaching $384.5. About 1.23M shares traded or 78.10% up from the average. The Sherwin-Williams Company (NYSE:SHW) has risen 26.25% since May 24, 2017 and is uptrending. It has outperformed by 14.70% the S&P500.

Analysts await GlaxoSmithKline plc (NYSE:GSK) to report earnings on July, 25. They expect $0.78 EPS, up 11.43% or $0.08 from last year’s $0.7 per share. GSK’s profit will be $1.92B for 12.88 P/E if the $0.78 EPS becomes a reality. After $0.68 actual EPS reported by GlaxoSmithKline plc for the previous quarter, Wall Street now forecasts 14.71% EPS growth.

More important recent GlaxoSmithKline plc (NYSE:GSK) news were published by: Seekingalpha.com which released: “Xenon Pharma up 21% premarket on positive XEN1101 data” on May 15, 2018, also Streetinsider.com published article titled: “GlaxoSmithKline (GSK) Indian Consumer Unit Receives Frenzy of Interest – Economic Times”, Seekingalpha.com published: “ViiV Healthcare’s HIV med Juluca OK’d in Europe” on May 21, 2018. More interesting news about GlaxoSmithKline plc (NYSE:GSK) was released by: Seekingalpha.com and their article: “GlaxoSmithKline Q1 2018: Still Too Many Uncertainties” with publication date: April 29, 2018.

Choate Investment Advisors, which manages about $3.44B and $1954.06 billion US Long portfolio, upped its stake in Comcast Corp (NASDAQ:CMCSA) by 577 shares to 56,160 shares, valued at $2.25B in 2017Q4, according to the filing. It also increased its holding in Powershares Russell 1000 Enh by 1.10M shares in the quarter, for a total of 3.24M shares, and has risen its stake in Travelers Companies Inc (NYSE:TRV).

Among 18 analysts covering GlaxoSmithKline (NYSE:GSK), 9 have Buy rating, 1 Sell and 8 Hold. Therefore 50% are positive. GlaxoSmithKline had 29 analyst reports since September 8, 2015 according to SRatingsIntel. The stock of GlaxoSmithKline plc (NYSE:GSK) has “Neutral” rating given on Tuesday, September 8 by Bank of America. The rating was downgraded by Citigroup on Wednesday, July 5 to “Neutral”. The firm earned “Underperform” rating on Wednesday, September 14 by BNP Paribas. The stock of GlaxoSmithKline plc (NYSE:GSK) has “Buy” rating given on Tuesday, January 16 by Barclays Capital. The firm has “Buy” rating given on Monday, November 27 by UBS. The company was upgraded on Thursday, July 14 by Jefferies. Investec initiated GlaxoSmithKline plc (NYSE:GSK) on Thursday, October 20 with “Buy” rating. The firm earned “Neutral” rating on Friday, June 16 by J P Morgan Chase Co. The rating was downgraded by Morgan Stanley to “Underweight” on Friday, September 8. BNP Paribas upgraded the stock to “Neutral” rating in Tuesday, September 15 report.

Analysts await The Sherwin-Williams Company (NYSE:SHW) to report earnings on July, 19. They expect $5.62 earnings per share, up 24.34% or $1.10 from last year’s $4.52 per share. SHW’s profit will be $523.00 million for 17.10 P/E if the $5.62 EPS becomes a reality. After $3.57 actual earnings per share reported by The Sherwin-Williams Company for the previous quarter, Wall Street now forecasts 57.42% EPS growth.

Investors sentiment decreased to 1.15 in Q4 2017. Its down 0.06, from 1.21 in 2017Q3. It dropped, as 43 investors sold SHW shares while 252 reduced holdings. 117 funds opened positions while 221 raised stakes. 68.54 million shares or 1.28% less from 69.43 million shares in 2017Q3 were reported. Moreover, Bradley Foster & Sargent Ct has 0.12% invested in The Sherwin-Williams Company (NYSE:SHW). Lipe And Dalton reported 0.71% stake. Cypress Group Inc has 4,366 shares. Apg Asset Management Nv has 226,580 shares for 0.14% of their portfolio. Goldman Sachs Incorporated has invested 0.08% in The Sherwin-Williams Company (NYSE:SHW). Js Mgmt Limited Liability Com stated it has 2.38% of its portfolio in The Sherwin-Williams Company (NYSE:SHW). Fishman Jay A Limited Mi stated it has 8,300 shares. Nomura Asset Communication accumulated 0.06% or 12,226 shares. Zurcher Kantonalbank (Zurich Cantonalbank) reported 21,605 shares. Amalgamated Fincl Bank holds 0.12% of its portfolio in The Sherwin-Williams Company (NYSE:SHW) for 10,830 shares. First Mercantile Company has 0.05% invested in The Sherwin-Williams Company (NYSE:SHW). Ballentine Ptnrs Limited Liability has 0.01% invested in The Sherwin-Williams Company (NYSE:SHW). Georgia-based Advisory Networks Ltd Company has invested 0.05% in The Sherwin-Williams Company (NYSE:SHW). Ls Advsrs Lc reported 6,982 shares or 0.17% of all its holdings. 6,182 are owned by Colony Gp Limited Liability Corporation.

More important recent The Sherwin-Williams Company (NYSE:SHW) news were published by: Fool.com which released: “Sherwin-Williams (SHW) Q1 2018 Earnings Conference Call Transcript” on April 25, 2018, also Seekingalpha.com published article titled: “Tracking Dan Loeb’s Third Point Portfolio – Q1 2018 Update”, Seekingalpha.com published: “Ask Sherwin Williams” on May 18, 2018. More interesting news about The Sherwin-Williams Company (NYSE:SHW) was released by: Seekingalpha.com and their article: “Sherwin Williams (SHW) Industry Overview – Slideshow” with publication date: May 23, 2018.

Since March 14, 2018, it had 0 insider purchases, and 1 sale for $306,945 activity.

Public Sector Pension Investment Board, which manages about $15.20B US Long portfolio, upped its stake in F M C Corp (NYSE:FMC) by 16,300 shares to 31,230 shares, valued at $2.96M in 2017Q4, according to the filing. It also increased its holding in Hp Inc by 60,019 shares in the quarter, for a total of 149,605 shares, and has risen its stake in Johnson & Johnson (NYSE:JNJ).

The Sherwin-Williams Company (NYSE:SHW) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts